000 | 01928 a2200553 4500 | ||
---|---|---|---|
005 | 20250517134229.0 | ||
264 | 0 | _c20170926 | |
008 | 201709s 0 0 eng d | ||
022 | _a1349-7006 | ||
024 | 7 |
_a10.1111/cas.13170 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNishioka, Chie | |
245 | 0 | 0 |
_aMicroRNA-9 plays a role in interleukin-10-mediated expression of E-cadherin in acute myelogenous leukemia cells. _h[electronic resource] |
260 |
_bCancer science _cApr 2017 |
||
300 |
_a685-695 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_a3' Untranslated Regions _xgenetics |
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCadherins _xgenetics |
650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCpG Islands _xgenetics |
650 | 0 | 4 |
_aCytarabine _xpharmacology |
650 | 0 | 4 |
_aDNA (Cytosine-5-)-Methyltransferases _xgenetics |
650 | 0 | 4 |
_aDNA Methylation _xdrug effects |
650 | 0 | 4 | _aDNA Methyltransferase 3A |
650 | 0 | 4 |
_aGene Expression Regulation, Leukemic _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-10 _xpharmacology |
650 | 0 | 4 |
_aLeukemia, Myeloid _xdrug therapy |
650 | 0 | 4 |
_aMesenchymal Stem Cells _xdrug effects |
650 | 0 | 4 | _aMice, Inbred NOD |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aMicroRNAs _xgenetics |
650 | 0 | 4 | _aRNA Interference |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aIkezoe, Takayuki | |
700 | 1 | _aPan, Bin | |
700 | 1 | _aXu, Kailin | |
700 | 1 | _aYokoyama, Akihito | |
773 | 0 |
_tCancer science _gvol. 108 _gno. 4 _gp. 685-695 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/cas.13170 _zAvailable from publisher's website |
999 |
_c26803856 _d26803856 |